large_Trajan investor site.webp

medium_Trajan investor site.webp

small_Trajan investor site.webp

thumbnail_Trajan investor site.webp

xlarge_Trajan investor site.webp

xsmall_Trajan investor site.webp

Trajan investor site.webp

We’re an Australian headquartered, global developer and manufacturer of analytical and life sciences products and devices, founded to have a positive impact on human well-being. We do this through consumable products, devices and solutions that are used in the analysis of biological, food, water, and other environmental samples. Through our portfolio and technology pipeline we’re supporting the move towards decentralised, personalised data-based healthcare.

large_Screen_Shot_2021_04_22_at_12_09_21_pm_b4ffeb8403.png

medium_Screen_Shot_2021_04_22_at_12_09_21_pm_b4ffeb8403.png

small_Screen_Shot_2021_04_22_at_12_09_21_pm_b4ffeb8403.png

thumbnail_Screen_Shot_2021_04_22_at_12_09_21_pm_b4ffeb8403.png

xsmall_Screen_Shot_2021_04_22_at_12_09_21_pm_b4ffeb8403.png

Screen_Shot_2021_04_22_at_12_09_21_pm_b4ffeb8403.png

Trajan has built a global infrastructure of operations in Europe, the US, and Asia, with seven dedicated precision manufacturing facilities in Australia, Europe, Malaysia, and the US, and a workforce of more than 650 people. Trajan’s global footprint is specifically designed to support future growth at scale and in close proximity to key customers.

Louisville_Version_48ce2430fa.gif

Trajan’s analytical products and components are sold to a broad range of participants in the analytical science industry, including large OEMs, pharmaceutical, food and CRO laboratories and scientific distribution companies.

thumbnail_Analytical_92923ba1a1.webp

xsmall_Analytical_92923ba1a1.webp

Analytical_92923ba1a1.webp

Trajan's life sciences solutions focus on areas directly related to human health. We enhance and optimise workflows with a variety of automated preparative or sample collection systems ready to integrate into laboratories, or generate custom solutions for life science research and development.

large_About_us_2_1b7b6d9b39.webp

medium_About_us_2_1b7b6d9b39.webp

small_About_us_2_1b7b6d9b39.webp

thumbnail_About_us_2_1b7b6d9b39.webp

xlarge_About_us_2_1b7b6d9b39.webp

xsmall_About_us_2_1b7b6d9b39.webp

About_us_2_1b7b6d9b39.webp

John graduated from the University of Queensland in 1991 before embarking on a 10-year international sporting career with the Australian rugby team from 1991, captaining the Wallabies from 1996 until 2001. John has served as an executive, adviser, director and investor in a number of listed and unlisted private organisations. John co-founded the Mettle Group in 2003 - a corporate consultancy which was acquired by Chandler Macleod in 2007. John currently sits on the ASX boards of Magellan Financial Group and Flight Centre Travel Group. He also sits on the board of Fuji Xerox - Document Management Solutions and Executive Health Solutions. He recently stepped down from his role as a Director of The Palladium Group and continues to serve as a consultant to major Australian companies, including Westpac. John has been a regular columnist in both the Australian Financial Review and The Australian over the last 20 years and is the author of two books, Learning from Legends Sport and Learning from Legends Business. He is the Chair of the World Rugby Hall of Fame Selection Panel and on the Rugby Australia Bid Advisory Board for the Rugby World Cup 2027. He was made a Member of the Order of Australia in 1999 for services to the community and rugby and is a Patron of the Melanoma Foundation, Hearts in Union and the Champagnat Trust. John holds a Bachelor of Arts (Psychology) from the University of Queensland and is a graduate of the Australian Institute of Company Directors.

large_John_Eales_Edit_dbd863f120.png

medium_John_Eales_Edit_dbd863f120.png

small_John_Eales_Edit_dbd863f120.png

thumbnail_John_Eales_Edit_dbd863f120.png

xsmall_John_Eales_Edit_dbd863f120.png

John_Eales_Edit_dbd863f120.png

Independent Non-Executive Chair

Stephen co-founded Trajan in 2011. Stephen leads Trajan’s senior management team and the Company’s global operations. Since entering the analytical science industry in 1984, Stephen has held several senior leadership roles in the industry, both in Australia and internationally. Immediately prior to co-founding Trajan, Stephen was the Chief Executive Officer of SGE Analytical Science. Other significant industry roles include Managing Director of PerkinElmer Australia and Africa, Director of Marketing at Vision Systems (since acquired by Danaher), Managing Director of Selby-Biolab and other senior roles at Varian Instruments (now Agilent Technologies) in both Australia and the US. Stephen is responsible for the design and implementation of Trajan’s strategic business plan and has led the negotiations of key customer and distribution agreements, the completion of Trajan’s acquisitions and the establishment of Trajan’s technological pipeline. Stephen holds a Bachelor of Applied Science from RMIT University.

large_Stephen_Tomisich_Edit_51c9757b93.png

medium_Stephen_Tomisich_Edit_51c9757b93.png

small_Stephen_Tomisich_Edit_51c9757b93.png

thumbnail_Stephen_Tomisich_Edit_51c9757b93.png

xsmall_Stephen_Tomisich_Edit_51c9757b93.png

Stephen_Tomisich_Edit_51c9757b93.png

CEO & Founder

Robert is Head of Corporate Development and General Counsel at Trajan. Robert has global responsibility for the strategic growth of Trajan’s business through mergers and acquisitions, licensing arrangements, and commercial relationships with Trajan’s industry, academic, government and research partners in the scientific and medical sectors globally. As Trajan’s General Counsel he also has responsibility for the negotiation and execution of Trajan’s investments and transactions, as well as for its broader legal requirements. Prior to joining Trajan, Robert had a 15-year career in law including as a partner at Page Seager Lawyers before spending six years with KPMG Corporate Finance. Robert holds a Bachelor of Arts and Bachelor of Laws, as well as an MBA from the University of Tasmania. Robert is a graduate of the Australian Institute of Company Directors.

large_Rob_Edit_159e3399c8.png

medium_Rob_Edit_159e3399c8.png

small_Rob_Edit_159e3399c8.png

thumbnail_Rob_Edit_159e3399c8.png

xsmall_Rob_Edit_159e3399c8.png

Rob_Edit_159e3399c8.png

Executive Director & Head of Corporate Development and General Counsel

Tiffiny brings operational, risk and strategy expertise gained over a 30-year career spanning consumer goods, manufacturing, professional services and the finance sectors. Tiffiny is currently a senior leader at Westpac Group where she has served since 2015. She is the Director of Root Cause, and previously held roles as General Manager Premium Bank Victoria and Head of Customer Advocate Office. Prior to Westpac, Tiffiny held senior leadership, operational and strategy roles across Australia and Asia for global organisations including Nestle Australia, Nestle Japan, SCA Hygiene, Mondelez International and Procter & Gamble where she successfully delivered organisational transformation, performance turnaround and market growth across business and consumer sectors. Tiffiny has a deep understanding of the Trajan businesses, having previously acted as a board advisor to Trajan. Tiffiny holds a Bachelor of Arts from Sydney University and is a graduate of the Australian Institute of Company Directors.

large_Tiffany_Lewin_Edit_d28421f9b2.png

medium_Tiffany_Lewin_Edit_d28421f9b2.png

small_Tiffany_Lewin_Edit_d28421f9b2.png

thumbnail_Tiffany_Lewin_Edit_d28421f9b2.png

xsmall_Tiffany_Lewin_Edit_d28421f9b2.png

Tiffany_Lewin_Edit_d28421f9b2.png

Non-Executive Director

Dr Khanna has over 40 years of experience in analytical science, business leadership and laboratory application software. In 1981, Dr Khanna co-founded Dynamic Solutions, a software-engineering firm dedicated to providing computing solutions to the scientific and engineering community. The company’s data management software became a leader in transitioning the analytical instrument industry to automated system control and data analysis, before being acquired by Waters Corporation in 1986. Dr Khanna went on to hold various senior management roles at Waters Corporation, including Vice-President and General Manager of the Data Products Group. In 2002, Dr Khanna was appointed Vice-President, Worldwide Marketing, and most recently Dr Khanna was Senior Vice President of several key Waters Corporation businesses including Informatics, Service, and Chemistry – along with being a member of the Corporate Executive Committee. Dr Khanna retired from Waters Corporation at the end of 2017 but remains closely connected to the industry, participating on several Boards and providing strategic advisory services. Dr Khanna holds a Bachelor of Science (Chemical Engineering) from Purdue University and a doctorate in chemical engineering from California Institute of Technology where he was a National Science Foundation Fellow.

large_Rohit_Khanna_Edit_2_22fc02bffb.png

medium_Rohit_Khanna_Edit_2_22fc02bffb.png

small_Rohit_Khanna_Edit_2_22fc02bffb.png

thumbnail_Rohit_Khanna_Edit_2_22fc02bffb.png

xsmall_Rohit_Khanna_Edit_2_22fc02bffb.png

Rohit_Khanna_Edit_2_22fc02bffb.png

Sara is an experienced Non-Executive Director (NED) with financial and operational experience across more than 20 years in a range of industries including technology, education, NFP and resources. Sara currently serves as NED and Chair of the Audit and Risk Committee for Trajan, Syrah Resources, Nuix Ltd and Uniting NSW.ACT; and is also a Trustee of the Sydney Opera House.  
Sara’s previous executive positions included Chief Financial Officer of IBM Australia/New Zealand, Head of Internal Audit for IBM Asia Pacific and Vice-Principal (Operations) at the University of Sydney.   
Sara is a Fellow of CPA Australia and a Fellow of the Australian Institute of Company Directors. 

large_Sara_Edit_bc9afa02fa.png

medium_Sara_Edit_bc9afa02fa.png

small_Sara_Edit_bc9afa02fa.png

thumbnail_Sara_Edit_bc9afa02fa.png

xsmall_Sara_Edit_bc9afa02fa.png

Sara_Edit_bc9afa02fa.png

Alister joined Trajan as Chief Financial Officer in 2011. Alister has experience in senior financial and operational leadership roles with ASX listed life science companies. Prior to joining Trajan, Alister was the CFO of Avecho Biotechnology Ltd. This followed almost nine years as a controller at Vision Systems, which was acquired by Danaher. Alister is a Certified Practising Accountant. Alister holds a Bachelor of Business from Victoria University and Graduate Diploma in Accounting from Monash University.

large_Alister_Hodges_Edit_b4b442f7e2.png

medium_Alister_Hodges_Edit_b4b442f7e2.png

small_Alister_Hodges_Edit_b4b442f7e2.png

thumbnail_Alister_Hodges_Edit_b4b442f7e2.png

xsmall_Alister_Hodges_Edit_b4b442f7e2.png

Alister_Hodges_Edit_b4b442f7e2.png


Andrew has 40 years of experience in R&D and leads a multidisciplinary team of scientists and engineers on a diverse range of projects from medical device development, separation science instrumentation prototyping, through to consumables for the global analytical science community. Andrew has been responsible for the execution of a range of collaborative programs with the Australian academic and medical research community focused on the translation of research outcomes into new product development. Prior to his time at Trajan and SGE Analytical Science, Andrew was the Chief Science Officer at Proteome Systems. Prior to Andrew’s business leadership roles, he had a distinguished career in academia. Andrew is currently Enterprise Professor at the University of Melbourne’s School of Chemistry. He has an ongoing role in mentoring undergraduate and postgraduate scientists and engineers. Andrew holds a Bachelor of Science (Honours) and a PhD in Biotechnology from Macquarie University.

large_Andrew_Gooley_Edit_0b209323b8.png

medium_Andrew_Gooley_Edit_0b209323b8.png

small_Andrew_Gooley_Edit_0b209323b8.png

thumbnail_Andrew_Gooley_Edit_0b209323b8.png

xsmall_Andrew_Gooley_Edit_0b209323b8.png

Andrew_Gooley_Edit_0b209323b8.png

Chief Scientific Officer

Nigel provides operational leadership across Trajan’s business. His responsibilities include global operational, manufacturing, production engineering and supply chain operations. Nigel has 20 years of leadership experience in pharmaceuticals, medical devices and scientific instruments. Prior to joining Trajan, Nigel was Europe General Manager & Director of Europe, Middle East & Africa (EMEA) Regional Operations at Pfizer Inc. and APAC Head, Supply Chain at Mayne Pharma. Nigel holds a Bachelor of Science – Chemistry (Honours) from Monash University and a Diploma in Education from Melbourne University.

large_Nigel_Gilligan_Edit_35ea4611cd.png

medium_Nigel_Gilligan_Edit_35ea4611cd.png

small_Nigel_Gilligan_Edit_35ea4611cd.png

thumbnail_Nigel_Gilligan_Edit_35ea4611cd.png

xsmall_Nigel_Gilligan_Edit_35ea4611cd.png

Nigel_Gilligan_Edit_35ea4611cd.png

Chief Operations Officer

Sam is the head of the Trajan’s global commercial team and is also a key member of the Company’s business development team. Sam is responsible for the customer-facing commercial organisation, providing customer and market insights and identifying and executing project based opportunities. Sam has 20 years of leadership experience in technical and commercial roles in analytical, life sciences and engineering companies. Prior to joining Trajan, Sam was CEO at Bigham Ag and Global VP - Corporate Development at IMI Norgren. Sam holds a Bachelor of Engineering (Honours) in Automotive Engineering Design, from Coventry University.

About Us

Enriching personal health through scientific tools and solutions.

Specialised manufacturing facilities; global infrastructure

Our Businesses

Analytical Products

Life Sciences Solutions

Corporate history

Board & Management

John Eales

Stephen Tomisich

Robert Lyon

Tiffiny Lewin

Dr Rohit Khanna

Sara Watts

Alister Hodges

Andrew Gooley PhD

Nigel Gilligan

Sam Evans

Investor Contact

Quick Links